Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Allergic Conjunctivitis

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Allergic Conjunctivitis

Shad Baab et al.
Free Books & Documents

Excerpt

Allergic conjunctivitis is a common, under-appreciated, and largely benign condition. Allergic conjunctivitis prevalence has increased over the past decade, making it one of clinical practice's most frequently encountered conditions. Allergic conjunctivitis results from various factors, including genetics, inflammation, air pollution, atopy, pollen exposure, and contact with pets. Allergic conjunctivitis can convert to keratoconjunctivitis and may result in a visual decline. While rarely posing a threat to vision, it can significantly impair patients' quality of life.

Simple allergic conjunctivitis can be classified into 3 subtypes: acute, seasonal, and perennial. Additionally, allergic conjunctivitis encompasses a broad range of conditions, including seasonal allergic conjunctivitis (SAC), perennial allergic conjunctivitis (PAC), vernal keratoconjunctivitis (VKC), and atopic keratoconjunctivitis (AKC).

While VKC and AKC exhibit distinct clinical and pathophysiological features from SAC and PAC, specific markers remain consistent.

Giant papillary conjunctivitis (GPC) is another condition that arises from contact lens use or ocular prostheses-related microtrauma. Treatment and certain aspects of pathophysiology show considerable overlap between atopic conjunctivitis (VKC, AKC) and giant papillary conjunctivitis. Therefore, these conditions are all classified as ocular allergies. Initial treatment strategies may be similar, although outcomes and complication rates vary.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Shad Baab declares no relevant financial relationships with ineligible companies.

Disclosure: Patrick Le declares no relevant financial relationships with ineligible companies.

Disclosure: Bharat Gurnani declares no relevant financial relationships with ineligible companies.

Disclosure: Eilene Kinzer declares no relevant financial relationships with ineligible companies.

References

    1. La Rosa M, Lionetti E, Reibaldi M, Russo A, Longo A, Leonardi S, Tomarchio S, Avitabile T, Reibaldi A. Allergic conjunctivitis: a comprehensive review of the literature. Ital J Pediatr. 2013 Mar 14;39:18. - PMC - PubMed
    1. Labib BA, Chigbu DI. Therapeutic Targets in Allergic Conjunctivitis. Pharmaceuticals (Basel) 2022 Apr 28;15(5) - PMC - PubMed
    1. Villegas BV, Benitez-Del-Castillo JM. Current Knowledge in Allergic Conjunctivitis. Turk J Ophthalmol. 2021 Feb 25;51(1):45-54. - PMC - PubMed
    1. Katelaris CH. Ocular allergy in the Asia Pacific region. Asia Pac Allergy. 2011 Oct;1(3):108-14. - PMC - PubMed
    1. Moote W, Kim H, Ellis AK. Allergen-specific immunotherapy. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):53. - PMC - PubMed

Publication types

LinkOut - more resources